Hysensbio
Innovative therapeutics for dental disease based on cell activation technology
Hysensbio was founded in 2016, is headquartered in Gwacheon, South Korea, lists 11–50 employees, and has $3.6M in recorded funding across 3 rounds.
- Headquarters
- Gwacheon, Gyeonggi
- Employees
- 11–50
- Founded
- 2016
- Business Model
- B2B
- Website
- hysensbio.com
- Total Funding
- $3.6M
- Last Round
- $1.6M Corporate RoundMay 2026
- Rounds
- 3
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 3 funding rounds and 4 investors for this company. The full record is or through the API.
About
HysensBio is a South Korean biotechnology company founded in 2016 by Professor Ju-Cheol Park of Seoul National University School of Dentistry. The company develops innovative therapeutic products for dental diseases based on over 20 years of foundational dental research. HysensBio's core technology focuses on odontoblast (dental pulp cell) activation and periodontal ligament fibroblast activation, enabling treatments for dental hypersensitivity (sensitive teeth), dental caries, and periodontal disease. Its lead candidate KH-001 is in Phase 2 clinical trials in the United States for dental hypersensitivity, with additional pipeline programs for periodontal tissue regeneration. HysensBio is headquartered in Gwacheon, Gyeonggi-do, South Korea, and has received recognition including the IR52 Jang Young-shil Award for technology innovation and the 2025 Prime Minister's Award for venture startup promotion.
Summary
Hysensbio is a Biotech company based in Gwacheon, South Korea, founded in 2016. It lists 11–50 employees. It has raised $3.6M in total across 3 rounds, most recently a $1.6M Corporate Round in May 2026. Investors include Orion Capital Asia, Korea Investment Partners and Solidus Investment.
Tech & App Stack
1 technology or app tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
May 2026
Sign up to see all 3 events
Funding: Corporate Round through Venture Round. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/hysensbio"><img src="https://indexed.vc/api/badge/company/hysensbio" alt="Hysensbio on Indexed.vc" width="260" height="76" /></a>